Myocardial infarction in patients with severe beta thalassaemia: a case series
Dublin Core
Title
Myocardial infarction in patients with severe beta thalassaemia: a case series
Subject
Cardiac disease remains a dominant if not the most important cause of morbidity and mortality
Description
Background Cardiac disease remains a dominant if not the most important cause of morbidity and mortality in
patients with thalassaemia, particularly in those with thalassaemia major. Myocardial infarction and coronary artery
disease however are rarely reported.
Case presentations Three older patients with three distinct thalassaemia syndromes presented with acute coronary
syndrome. Two were heavily transfused whilst the other was a minimally transfused patient. Both heavily transfused
patients had ST-elevation myocardial infarctions (STEMI) while the minimally transfused patient had unstable angina.
Coronary angiogram (CA) was normal in two patients. One patient who developed a STEMI had a 50% plaque. All
three were managed as standard ACS, although the aetiology appeared non-atherogenic.
Conclusions The exact etiology of the presentation, remains a mystery and therefore the rational use of thrombolytic
therapy, carrying out angiogram in the primary setting, using and continuing antiplatelet and high dose statins all
remains unclear in this sub group of patients.
patients with thalassaemia, particularly in those with thalassaemia major. Myocardial infarction and coronary artery
disease however are rarely reported.
Case presentations Three older patients with three distinct thalassaemia syndromes presented with acute coronary
syndrome. Two were heavily transfused whilst the other was a minimally transfused patient. Both heavily transfused
patients had ST-elevation myocardial infarctions (STEMI) while the minimally transfused patient had unstable angina.
Coronary angiogram (CA) was normal in two patients. One patient who developed a STEMI had a 50% plaque. All
three were managed as standard ACS, although the aetiology appeared non-atherogenic.
Conclusions The exact etiology of the presentation, remains a mystery and therefore the rational use of thrombolytic
therapy, carrying out angiogram in the primary setting, using and continuing antiplatelet and high dose statins all
remains unclear in this sub group of patients.
Creator
Anuja Premawardhena1*, Shamila De Silva1
, Megha Rajapaksha2
, Vishaka Ratnamalala3
,
Jemimah Nallarajah4 and Gamini Galappatthy4
, Megha Rajapaksha2
, Vishaka Ratnamalala3
,
Jemimah Nallarajah4 and Gamini Galappatthy4
Source
https://doi.org/10.1186/s12245-023-00495-z
Date
2023
Contributor
peri irawan
Format
pdf
Language
english
Type
text
Files
Collection
Citation
Anuja Premawardhena1*, Shamila De Silva1
, Megha Rajapaksha2
, Vishaka Ratnamalala3
,
Jemimah Nallarajah4 and Gamini Galappatthy4, “Myocardial infarction in patients with severe beta thalassaemia: a case series,” Repository Horizon University Indonesia, accessed April 11, 2026, https://repository.horizon.ac.id/items/show/12125.